Last Posted: Sep 08, 2017
- Chimeric Antigen Receptor (CAR) T-Cell Therapy- Patient Page
JM Pagel et al, JAMA Oncology, Sep 7, 2017 - Targeting Immune Checkpoints in Cancer Therapy
SL Topalian, JAMA, Sep 8, 2017 - Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
Albaba Hamzeh et al. PharmacoEconomics 2017 Aug - FDA Approves First CAR-T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia
NIH Director's blog, September, 2p017 - CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers
August 31, 2017 - Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.
Reck Martin et al. The New England journal of medicine 2017 Aug (9) 849-861 - Gut bacteria associated with cancer immunotherapy response in melanoma
Science Mag, August 20, 2017 - NCI study identifies essential genes for cancer immunotherapy
NCI, August 7, 2017 - Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Sonneveld Pieter et al. Blood 2016 Jun 127(24) 2955-62 - Identification of essential genes for cancer immunotherapy
SJ Patel et al, Nature August 7, 2017 - Genetic biomarker for cancer immunotherapy
S Goswami et al, Science, July 28, 2017 - Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.
Johanns Tanner M et al. Cancer journal (Sudbury, Mass.) 23(2) 125-130 - Longitudinal analysis of treatment-induced genomic alterations in gliomas.
Erson-Omay E Zeynep et al. Genome medicine 2017 Feb 9(1) 12 - The science behind the story: Following a cancer vaccine from concept to proof of concept
T Ulrich, Broad Institute, July 6, 2017 - Precision Oncology: Gene Changes Predict Immunotherapy Response
NIH Director Blog, June 20, 2017 - Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
Schütte Moritz et al. Public health genomics 2017 Jun
.png)
No hay comentarios:
Publicar un comentario